The Use of Next-Generation Sequencing in Treating Non-Squamous Non-Small-Cell Lung Cancer

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider how next-generation sequencing (NGS) informs treatment of lung cancer patients in providing information on tumor mutational burden, microsatellite instability, unique targetable genomic signatures, as well as novel targets that may be best addressed in a clinical trial.

Related Videos

January 20, 2016

Therapeutic Agents in Clinical Trials

Dr Wainberg and Dr Gerson identify some of the challenges of preclinical models versus clinical trials.

October 23, 2018

Improving Efficiencies in Oncology Biomarker Testing

Drs. Roy Herbst and David Rimm discuss ways in which the time required to complete biomarker testing can be reduced, from obtaining and processing tissues, performing the testing, evaluating results, and reporting results to the cancer care team.